TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T15797	SET and MYND domain-containing protein 2	B1QW2K	N-((1R,3r,5S)-8-((4-(Benzylamino)piperidin-1-yl)sulfonyl)-8-azabicyclo[3.2.1]octan-3-yl)-6-chloro-2-oxoindoline-5-carboxamide	Investigative	118946368	C28H34ClN5O4S	572.1	C1C[C@H]2CC(C[C@@H]1N2S(=O)(=O)N3CCC(CC3)NCC4=CC=CC=C4)NC(=O)C5=C(C=C6C(=C5)CC(=O)N6)Cl	IC50 ~ 50000 nM	Poor binder
T15797	SET and MYND domain-containing protein 2	B29ZVO	6,7-Dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine	Investigative	78357767	C23H35N5O2	413.6	COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCCC3)NCCCCCN4CCCC4)OC	IC50 ~ 100000 nM	Poor binder
T15797	SET and MYND domain-containing protein 2	B8D9YH	(2~{S})-5-[2-(3-Aminocarbonylphenyl)ethyl-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl]amino]-2-azanyl-pentanoic acid	Investigative	134159782	C24H32N8O6	528.6	C1=CC(=CC(=C1)C(=O)N)CCN(CCC[C@@H](C(=O)O)N)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)O	IC50 = 62000 nM	Poor binder
T15797	SET and MYND domain-containing protein 2	BRH94C	6-Chloro-2-oxo-N-((1R,3r,5S)-8-(((1-(4,4,4-trifluorobutyl)piperidin-4-yl)methyl)sulfonyl)-8-azabicyclo[3.2.1]octan-3-yl)indoline-5-carboxamide	Investigative	118946372	C26H34ClF3N4O4S	591.1	C1C[C@H]2CC(C[C@@H]1N2S(=O)(=O)CC3CCN(CC3)CCCC(F)(F)F)NC(=O)C4=C(C=C5C(=C4)CC(=O)N5)Cl	IC50 ~ 50000 nM	Poor binder